Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Drug Targets|February 4, 2012
Novel approaches to study the involvement of α7-nAChR in human diseasesEleonora Palma, Luca Conti, Cristina Roseti, et al.Frontiers in Cellular Neuroscience|July 23, 2013
Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsyPierangelo Cifelli, Eleonora Palma, Cristina Roseti, et al.Basic & Clinical Pharmacology & Toxicology|February 3, 2023
Betaine-The dark knight of the brainManan Bhatt, Angela Di Iacovo, Tiziana Romanazzi, et al.Membranes|October 27, 2022
The "www" of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters ResearchManan Bhatt, Angela Di Iacovo, Tiziana Romanazzi, et al.Current Pharmaceutical Design|August 12, 2017
Modulation of GABAA Receptors in the Treatment of EpilepsyEleonora Palma, Gabriele Ruffolo, Pierangelo Cifelli, et al.Epilepsia|June 4, 2011
Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortexLuca Conti, Eleonora Palma, Cristina Roseti, et al.Journal of Neurochemistry|December 10, 2024
The kinase LRRK2 is required for the physiological function and expression of the glial glutamate transporter EAAT2 (SLC1A2)Angela Di Iacovo, Chiara D'Agostino, Manan Bhatt, et al.Epilepsia|October 12, 2018
A novel GABAergic dysfunction in human Dravet syndromeGabriele Ruffolo, Pierangelo Cifelli, Cristina Roseti, et al.The Journal of Physiology|April 12, 2022
Functional characterization of Atlantic salmon (Salmo salar L.) PepT2 transportersFrancesca Vacca, Ana S Gomes, Koji Murashita, et al.SLAS Discovery : Advancing Life Sciences R & D|April 7, 2021
Characterization of Transport Activity of SLC11 Transporters in Xenopus laevis Oocytes by Fluorophore QuenchingRaffaella Cinquetti, Francesca Guia Imperiali, Salvatore Bozzaro, et al.Pageof 3